发明名称 |
Compounds for the Treatment of Hepatitis C |
摘要 |
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
|
申请公布号 |
US2013078214(A1) |
申请公布日期 |
2013.03.28 |
申请号 |
US201213625186 |
申请日期 |
2012.09.24 |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY;BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
WANG TAO;SUN LI-QIANG;SCOLA PAUL MICHAEL;ZHANG ZHONGXING;ZHAO QIAN |
分类号 |
A61K31/529;A61K38/13;A61K38/20;A61K38/21;A61P31/20;C07D498/08;C07D498/10;C07D498/18 |
主分类号 |
A61K31/529 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|